N1BI34

Neurocrine Biosciences, Inc.

BR Healthcare Drug Manufacturers - Specialty & Generic

Latest week
10 Jul 2026
Close
45.049999
Fair value
34.969615
Next-week expectancy
Undecided 54.70%
Sharemaestro

N1BI34 Chart Pack

Neurocrine Biosciences, Inc.

Exchange
SAO
Latest week
10 Jul 2026
Close
45.049999
Fair value
34.969615
Next-week expectancy
Undecided 54.70%
Generated
17 Jul 2026 18:18
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, N1BI34 rose 39.17%, moving from 32.37 to 45.05. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 9.28 and has improved across the 12-week window. Market Dynamics is 1.00 on the latest week. Next-week expectancy is undecided at 54.70% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
45.05
12-Week Change
39.17%
Trend Signal
Active
Next-Week Expectancy
Undecided 54.70%
Signal Weeks
3 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
9.28
Market Dynamics
1.00

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
45.05
12-Week Change
39.17%
Trend Signal
Active
Next-Week Expectancy
Undecided 54.70%
Signal Weeks
3 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
9.28
Market Dynamics
1.00

Over the latest 12 completed weeks ending 2026-07-10, N1BI34 rose 39.17%, moving from 32.37 to 45.05. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 9.28 and has improved across the 12-week window. Market Dynamics is 1.00 on the latest week. Next-week expectancy is undecided at 54.70% based on similar historical setup states.

Industry Peers

Brazil equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
BLAU3 Blau Farmacêutica S.A. SAO 10 Jul 2026 10.11 10.63 9.92 10.55 4.35%
HYPE3 Hypera S.A. SAO 10 Jul 2026 20.96 21.14 20.03 21.11 0.72%
P1RG34 Perrigo Company plc SAO 10 Jul 2026 51.74 51.74 51.74 51.74 0.00%
T1EV34 Teva Pharmaceutical Industries Limited SAO 10 Jul 2026 89.28 89.28 89.28 89.28 0.00%
TAKP34 Takeda Pharmaceutical Company Limited SAO 10 Jul 2026 82.32 82.32 82.32 82.32 0.00%
U2TH34 United Therapeutics Corporation SAO 10 Jul 2026 137.50 137.50 137.50 137.50 0.00%
Z1TS34 Zoetis Inc. SAO 10 Jul 2026 24.21 24.90 23.72 24.11 -0.41%
OFSA3 Ouro Fino Saúde Animal Participações S.A. SAO 10 Jul 2026 28.90 29.30 26.10 27.40 -5.19%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.